Comparison
6q Terminal Deletion Syndrome C4304514 vs 2 Hydroxyglutaric Aciduria C2746066
Clinical comparison between 6Q Terminal Deletion Syndrome and 2 Hydroxyglutaric Aciduria for differential diagnosis and treatment planning.
6q Terminal Deletion Syndrome C4304514
A chromosomal disorder involving deletion of genetic material at the end of chromosome 6, leading to developmental delays and variable physical features.
2 Hydroxyglutaric Aciduria C2746066
An organic acidemia where elevated acids accumulate in the body. It can cause neurological and developmental problems. Treatment focuses on supportive care and symptom management.
6 comparison axes
Onset
6q Terminal Deletion Syndrome C4304514
0-0
2 Hydroxyglutaric Aciduria C2746066
0-10
Onset patterns differ
Severity
6q Terminal Deletion Syndrome C4304514
severe
2 Hydroxyglutaric Aciduria C2746066
moderate
Different severity levels
Chronic
6q Terminal Deletion Syndrome C4304514
Chronic
2 Hydroxyglutaric Aciduria C2746066
Chronic
Differing course
Communicable
6q Terminal Deletion Syndrome C4304514
No
2 Hydroxyglutaric Aciduria C2746066
No
Different transmission
Body System
6q Terminal Deletion Syndrome C4304514
congenital
2 Hydroxyglutaric Aciduria C2746066
metabolic
Same/different system
Category
6q Terminal Deletion Syndrome C4304514
genetic
2 Hydroxyglutaric Aciduria C2746066
metabolic
Different category
Bottom line
6q-terminal-deletion-syndrome-C4304514 and 2-hydroxyglutaric-aciduria-C2746066 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q Terminal Deletion Syndrome C4304514 | 2 Hydroxyglutaric Aciduria C2746066 | Discriminating power |
|---|---|---|---|
| Developmental delay | May be present from early life with variable physical features; exact pattern is not established here. | May accompany neurological problems as abnormal metabolites accumulate. | Low |
| Onset timing | Supplied onset is at birth or the earliest period. | Supplied onset spans early childhood, from birth through about age 10. | Moderate |
| Systemic category | Congenital genetic disorder caused by terminal chromosome 6 deletion. | Metabolic organic acidemia with elevated acids and supportive management. | High |
When to favor each condition
Choose 6q Terminal Deletion Syndrome C4304514 when
Congenital developmental concerns with suspected chromosomal anomaly
The description supports a terminal chromosome 6 deletion rather than a metabolic acid accumulation.
Moderate
Need to explain variable physical features
Variable physical features are specifically described for the deletion syndrome.
Moderate
Genetic counseling about a chromosomal finding
Category and body-system data identify a congenital genetic condition.
High
Choose 2 Hydroxyglutaric Aciduria C2746066 when
Suspected organic acid accumulation
The description identifies elevated acids and a metabolic disorder.
High
Neurological or developmental problems with metabolic concern
Neurological and developmental effects are described, without a chromosomal deletion.
Moderate
Planning supportive symptom management
Supportive care and symptom management are explicitly described.
Moderate
How key tests differ
| Test | 6q Terminal Deletion Syndrome C4304514 | 2 Hydroxyglutaric Aciduria C2746066 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify deletion at the end of chromosome 6 when clinically indicated. | Not expected to establish this metabolic diagnosis. | A chromosomal result supports the left condition but does not exclude unrelated findings. |
| Organic acid testing | No characteristic organic-acid pattern is established by the supplied data. | May show elevated relevant acids; exact cutoffs are not supplied. | An abnormal metabolite result suggests, but does not by itself diagnose, the right condition. |
| Clinical genetics and metabolic evaluation | Focuses on congenital features and chromosomal confirmation. | Focuses on metabolic abnormalities and neurological course. | Specialist interpretation is required because overlap in developmental findings is possible. |
Prognosis comparison
6q Terminal Deletion Syndrome C4304514
- Outcome
- Potentially substantial developmental impact; precise prognosis is not established.
- Factors
- Severity is listed as severe, with variable features and a chronic course.
2 Hydroxyglutaric Aciduria C2746066
- Outcome
- Variable neurological and developmental impact; precise prognosis is not established.
- Factors
- Severity is listed as moderate, with chronic course and supportive management.
Time frame: From early life through long-term follow-up; exact timelines are unavailable.
Diagnosis confirmation, individual features, complications, and access to specialist care influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Developmental delay is described and severity is listed as severe. Developmental problems may occur; listed severity is moderate. Individual outcomes vary and are not quantified here. |
| Neurological problems | Not specifically established beyond developmental effects. Neurological problems are described. Do not infer a specific neurological complication without clinical evidence. |
| Chronic course | Described as chronic. Described as chronic. Both may require long-term follow-up; neither is communicable. |
Patient education highlights
- HighDifferent causes
One is a chromosomal deletion; the other is a metabolic acid disorder. Similar developmental concerns do not mean the same diagnosis.
- HighTesting limits
Abnormal genetic or metabolic results need specialist interpretation and do not replace a full clinical assessment.
- MediumCare planning
Management is individualized. Supportive care is described for the metabolic condition; no doses or universal treatment plan are established here.